Rejuvesol (Citra Labs LLC)
Welcome to the PulseAid listing for the Rejuvesol drug offered from Citra Labs LLC. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Citra Labs LLC |
| NON-PROPRIETARY NAME: | Sodium Pyruvate, Inosine, Adenine, Sodium Phosphate, Dibasic, and Sodium Phosphate, Monobasic, Monohydrate |
| SUBSTANCE NAME: | SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | EXTRACORPOREAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1997-02-26 |
| END MARKETING DATE: | 0000-00-00 |
Rejuvesol HUMAN PRESCRIPTION DRUG Details:
| Item Description | Rejuvesol from Citra Labs LLC |
| LABELER NAME: | Citra Labs LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | .55; 1.34; .034; .73; .311(g/50mL; g/50mL; g/50mL; g/50mL; g/50mL) |
| START MARKETING DATE: | 1997-02-26 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 23731-7000_39fa60ec-a741-4582-8159-7a4075a7e0ff |
| PRODUCT NDC: | 23731-7000 |
| APPLICATION NUMBER: | BN950522 |
Other SODIUM PYRUVATE; INOSINE; ADENINE; SODIUM PHOSPHATE, DIBASIC; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE Pharmaceutical Manufacturers / Labelers:
